- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN1069 | Recombinant Protein-Influenza A virus Hemagglutinin H6 (a.a.18 to 566) | Q80RX6 | 100 µg | 1195 | |
PN1070 | Recombinant Protein-Influenza A virus Neuraminidase N2 (a.a.36 to 451) | Q80RW3 | 100 µg | 1195 | |
PN1071 | Recombinant Protein-Influenza A virus Neuraminidase (a.a.51 to 449) | Q4U002 | 100 µg | 1195 | |
PN1072 | Recombinant Protein-Influenza A virus Nucleoprotein (a.a.51 to 498) | Q4U003 | 100 µg | 1195 | |
PN1073 | Recombinant Protein-Influenza A virus Hemagglutinin (a.a.25 to 568) | Q4U004 | 100 µg | 1195 | |
PN1074 | Recombinant Protein-Influenza A virus Hemagglutinin (a.a.51 to 568) | A0A248 | 100 µg | 1195 | |
PN1075 | Recombinant Protein-Influenza A virus Matrix protein 1 (a.a.21 to 252) | Q77NQ1 | 100 µg | 1195 | |
PN1076 | Recombinant Protein-Influenza A virus Matrix protein 2 (a.a.18 to 97) | Q9J456 | 100 µg | 1195 | |
PN1077 | Recombinant Protein-Influenza A virus Neuraminidase subtype 2 (a.a.31 to 469) | Q9J458 | 100 µg | 1195 | |
PN1078 | Recombinant Protein-Influenza A virus Matrix protein (a.a.21 to 252) | Q9EMB0 | 100 µg | 1195 | |
PN1079 | Recombinant Protein-Influenza A virus Nucleocapsid protein (a.a.21 to 498) | Q9EMB4 | 100 µg | 1195 | |
PN1080 | Recombinant Protein-Influenza A virus H5N1 Hemagglutinin (a.a.51 to 570) | C4P285 | 100 µg | 1195 | |
PN1081 | Recombinant Protein-Influenza A virus H5N1 Matrix protein M1 (a.a.35 to 252) | Q6R2G8 | 100 µg | 1195 | |
PN1082 | Recombinant Protein-Influenza A virus H5N1 Membrane ion channel M2 (a.a.18 to 97) | Q6R2G9 | 100 µg | 1195 | |
PN1083 | Recombinant Protein-Influenza A virus H4N5 Neuraminidase (a.a.51 to 472) | Q0KJ47 | 100 µg | 1195 | |
PN1084 | Recombinant Protein-Influenza A virus M1 protein (a.a.21 to 252) | Q5DL96 | 100 µg | 1195 | |
PN1085 | Recombinant Protein-Influenza A virus H3N8 Hemagglutinin (a.a.26 to 336) | C9W7X2 | 100 µg | 1195 | |
PN1086 | Recombinant Protein-Influenza A virus H2N9 Nonstructural protein 2 (a.a.21 to 121) | Q20P30 | 100 µg | 1195 | |
PN1087 | Recombinant Protein-Influenza A virus H12N1 Nucleocapsid protein (a.a.51 to 498) | Q2FCQ2 | 100 µg | 1195 | |
PN1088 | Recombinant Protein-Influenza A virus H2N5 Neuraminidase (a.a.51 to 473) | Q20W71 | 100 µg | 1195 | |
PN1089 | Recombinant Protein-Influenza A virus H1N1 Nonstructural protein 1 (a.a.21 to 237) | A4D6R9 | 100 µg | 1195 | |
PN1090 | Recombinant Protein-Influenza A virus H1N1 Hemagglutinin (a.a.18 to 575) | B2ZVN6 | 100 µg | 1195 | |
PN1091 | Recombinant Protein-Influenza A virus H2N9 Hemagglutinin (a.a.23 to 569) | Q6DWQ5 | 100 µg | 1195 | |
PN1092 | Recombinant Protein-Influenza A virus H1N1 Matrix protein 1 (a.a.21 to 252) | D1CP60 | 100 µg | 1195 | |
RPN1069 | cDNA-Influenza A virus Hemagglutinin H6 (a.a.18 to 566) | Q80RX6 | 2 µg | 2740 | |
RPN1070 | cDNA-Influenza A virus Neuraminidase N2 (a.a.36 to 451) | Q80RW3 | 2 µg | 2075 | |
RPN1071 | cDNA-Influenza A virus Neuraminidase (a.a.51 to 449) | Q4U002 | 2 µg | 1990 | |
RPN1072 | cDNA-Influenza A virus Nucleoprotein (a.a.51 to 498) | Q4U003 | 2 µg | 2235 | |
RPN1073 | cDNA-Influenza A virus Hemagglutinin (a.a.25 to 568) | Q4U004 | 2 µg | 2715 | |
RPN1074 | cDNA-Influenza A virus Hemagglutinin (a.a.51 to 568) | A0A248 | 2 µg | 2585 | |
RPN1075 | cDNA-Influenza A virus Matrix protein 1 (a.a.21 to 252) | Q77NQ1 | 2 µg | 1155 | |
RPN1076 | cDNA-Influenza A virus Matrix protein 2 (a.a.18 to 97) | Q9J456 | 2 µg | 800 | |
RPN1077 | cDNA-Influenza A virus Neuraminidase subtype 2 (a.a.31 to 469) | Q9J458 | 2 µg | 2190 | |
RPN1078 | cDNA-Influenza A virus Matrix protein (a.a.21 to 252) | Q9EMB0 | 2 µg | 1155 | |
RPN1079 | cDNA-Influenza A virus Nucleocapsid protein (a.a.21 to 498) | Q9EMB4 | 2 µg | 2385 | |
RPN1080 | cDNA-Influenza A virus H5N1 Hemagglutinin (a.a.51 to 570) | C4P285 | 2 µg | 2595 | |
RPN1081 | cDNA-Influenza A virus H5N1 Matrix protein M1 (a.a.35 to 252) | Q6R2G8 | 2 µg | 1085 | |
RPN1082 | cDNA-Influenza A virus H5N1 Membrane ion channel M2 (a.a.18 to 97) | Q6R2G9 | 2 µg | 800 | |
RPN1083 | cDNA-Influenza A virus H4N5 Neuraminidase (a.a.51 to 472) | Q0KJ47 | 2 µg | 2105 | |
RPN1084 | cDNA-Influenza A virus M1 protein (a.a.21 to 252) | Q5DL96 | 2 µg | 1155 | |
RPN1085 | cDNA-Influenza A virus H3N8 Hemagglutinin (a.a.26 to 336) | C9W7X2 | 2 µg | 1550 | |
RPN1086 | cDNA-Influenza A virus H2N9 Nonstructural protein 2 (a.a.21 to 121) | Q20P30 | 2 µg | 800 | |
RPN1087 | cDNA-Influenza A virus H12N1 Nucleocapsid protein (a.a.51 to 498) | Q2FCQ2 | 2 µg | 2235 | |
RPN1088 | cDNA-Influenza A virus H2N5 Neuraminidase (a.a.51 to 473) | Q20W71 | 2 µg | 2110 | |
RPN1089 | cDNA-Influenza A virus H1N1 Nonstructural protein 1 (a.a.21 to 237) | A4D6R9 | 2 µg | 1080 | |
RPN1090 | cDNA-Influenza A virus H1N1 Hemagglutinin (a.a.18 to 575) | B2ZVN6 | 2 µg | 2785 | |
RPN1091 | cDNA-Influenza A virus H2N9 Hemagglutinin (a.a.23 to 569) | Q6DWQ5 | 2 µg | 2730 | |
RPN1092 | cDNA-Influenza A virus H1N1 Matrix protein 1 (a.a.21 to 252) | D1CP60 | 2 µg | 1155 |
Influenza A virus cDNA and recombinant antigen
Influenza A virus is a subtype of the influenza virus that can cause respiratory illness in humans and animals. It is highly contagious and can lead to seasonal outbreaks (influenza pandemics). Symptoms include fever, cough, body aches, and fatigue. Vaccination and antiviral medications are available to prevent and treat Influenza A infections.
Influenza A virus antigen refers to a protein or substance present on the surface of the virus that can trigger an immune response. Antigens can be used in diagnostic tests to identify the presence of the virus and in vaccine development to stimulate immunity against the virus. Antigens from the Influenza A virus can vary, making it important to monitor and update vaccines accordingly to provide effective protection against new strains.
The Influenza A virus genome is the genetic material that makes up the virus and determines its characteristics and behavior. The genome of Influenza A virus is composed of RNA and is segmented into eight separate pieces, which can mix and match to create new strains of the virus. This genetic variability is one reason why the flu can be difficult to control, as new strains can emerge that are not recognized by the immune system or are resistant to current vaccines and antiviral drugs. The study of the Influenza A virus genome is important for understanding the biology of the virus, developing new diagnostic tests and treatments, and predicting the evolution of the virus.Here’s what you need to know about these proteins:
Hemagglutinin (HA) is a glycoprotein found on the surface of the influenza virus that is responsible for binding to host cells and initiating viral entry. H6 and H5N1 are specific subtypes of hemagglutinin.
Neuraminidase (NA) is another glycoprotein found on the surface of the virus that is involved in the release of new viral particles from infected cells. N2, H4N5, H2N5, and H2N9 are specific subtypes of neuraminidase.
Nucleoprotein (NP) and Nucleocapsid protein are both involved in viral RNA replication and packaging.
Matrix protein (M1 and M2) plays a crucial role in the assembly and release of new viral particles from infected cells.
Nonstructural proteins (NS1 and NS2) are involved in viral replication and inhibition of host immune responses.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple